Skip to content
Xiangbobo10 Blog

Patients Stopping Weight-Loss Jabs Gain Back Pounds Four Times Faster Than People Using Diet and Exercise

Image of medical injection and weighing machine
Obesity treatment involves ongoing approaches.

Fresh analysis suggests that individuals who come off popular slimming jabs like semaglutide or tirzepatide may regain lost weight much more quickly than those who end conventional diet and exercise programs.

Findings released in a major medical journal shows that while overweight individuals frequently drop about a fifth of their body weight while using the jabs, the weight comes back at an estimated rate of 0.8 kg per month upon discontinuation.

"Users purchasing these medications should be cognizant of the potential of fast weight regain when the treatment is stopped," stated researcher Dr. Susan Jebb.

That rate of regain suggests a return to starting weight within about 18 months.

Weighing Treatments

The analysis, which examined dozens of trials involving over 9,000 of patients, compared the outcomes of GLP-1 agonists with conventional dieting.

The team emphasize that people who lose weight through lifestyle changes alone typically have a less rapid weight regain—perhaps 100 grams monthly—once they finish.

Explaining the Fast Regain

Doctors suggest the mode of action of the jabs explains the accelerated weight return.

These medications mimic a natural hormone called glucagon-like peptide-1, which helps regulate feelings of fullness.

"Sustained high doses of GLP-1 levels far above than the body's typical production could lead to the system to generate a reduced amount of its own natural GLP-1, and may also lessen responsiveness to its effects," noted Dr. Adam Collins, a nutrition expert.

"Stopping of this medication leads to hunger is uncontrolled, making excessive eating far more likely."

An Ongoing Issue?

The NHS suggest the injections for individuals with obesity-related medical conditions, accompanied by prescribed diet and exercise modifications.

Professionals say that, considering the high risk of relapse, the treatment might need to be long-term.

This perspective is echoed by drug manufacturers, who say that the results "highlight the long-term nature of obesity," comparing it to managing diseases like diabetes.

User Experiences

Individuals who have discontinued the jabs describe a powerful return of cravings.

"I experienced a switch that goes on and you become extremely hungry," said an individual.

The struggle is worsened if individuals have not established sustainable dietary or behavioural modifications during treatment.

Growing Interest

Survey data suggest that a significant number of people in the UK have tried weight-loss jabs in the past year, with demand being substantial.

  • Adoption is greater among females than men.
  • The middle-aged age group shows the highest level of interest.
  • A large proportion obtain the medications through private healthcare rather than the NHS.

Ultimately, researchers stress that while these medications are effective tools for weight loss, they are not a standalone solution and maintained weight loss likely depends on ongoing lifestyle changes.

Written by

Jared Wood

HR strategist and tech enthusiast with over a decade of experience in talent management and innovation.

Xiangbobo10 Blog

Type to search articles.